11
Aug
Total Income for Q1FY24 grew 10.27% Y-o-Y to Rs. 143.31 crore. Company has set a target of achieving Rs. 750 crore revenue by FY26 Financial Highlights (Standalone) Ahmedabad (Gujarat) [India], August 11: Lincoln Pharmaceuticals Limited, one of India’s leading healthcare companies has reported a standalone net profit of Rs. 19.01 crore for the Q1 FY 2023-24 ended June 2023 as against net profit of Rs. 15.01 crore in Q1 FY2022-23, growth of 26.66% Y-o-Y. Total income for the quarter ended June 2023 was reported at Rs. 143.31 crore, higher by 10.27% Y-o-Y over total income of Rs. 129.97 crore in…
